Molecular Carcinogenesis

Article	Citations
Corrigendum	57
RETRACTION: “LncAPC Drives Wnt/Β‐Catenin Activation and Liver TIC Self‐Renewal Through EZH2 Mediated APC Transcriptional Inhibition”	34
A novel oncogene trigger transposable element derived‐1 promotes oral squamous cell carcinoma progression via evoking immune inhibition	29
Guangsangon E triggers mitochondria dysfunction and mitophagy in triple‐negative breast cancer and leads to non‐apoptotic cell death	28
USP9X deubiquitinates and stabilizes CDC123 to promote breast carcinogenesis through regulating cell cycle	28
The Role of HADHB in Mitochondrial Fatty Acid Metabolism During Initiation of Metastasis in ccRCC	28
Issue Information ‐ Ed Board	27
	26
The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway	26
Issue Information ‐ Ed Board	25
Hsa_circ_0088036 promotes nonsmall cell lung cancer progression by regulating miR‐1343‐3p/Bcl‐3 axis through TGFβ/Smad3/EMT signaling	24
	24
	24
Setting up clinical trials for success: Applying preclinical advances in combined TGFβ/PD‐L1 inhibition to ongoing clinical studies	23
Issue Information ‐ Ed Board	23
HNRNPC promotes estrogen receptor‐positive breast cancer cell cycle by stabilizing WDR77 mRNA in an m6A‐dependent manner	23
YAP‐LAMB3 axis dictates cellular resistance of pancreatic ductal adenocarcinoma cells to gemcitabine	22
ATP citrate lyase promotes the progression of hepatocellular carcinoma by activating the REGγ‐proteasome pathway	21
UBE2D1 promotes glioblastoma proliferation by modulating p21 ubiquitination	21
	20
TMED3 stabilizes SMAD2 by counteracting NEDD4‐mediated ubiquitination to promote ovarian cancer	20
	19
Pyroptosis‐related gene GSDMC indicates poor prognosis and promotes tumor progression by activating the AKT/mTOR pathway in lung squamous cell carcinoma	18
ACKR3 orchestrates Hedgehog signaling to promote renal cell carcinoma progression	18
Synergistic rescue of temperature‐sensitive p53 mutants by hypothermia and arsenic trioxide	18

Issue Information ‐ Ed Board	18
Monocarboxylate transporter 1 is a novel target for breast cancer stem like‐cell inhibition by diallyl trisulfide	18
	17
Helicobacter pylori infection associated DNA methylation in primary gastric cancer significantly correlates with specific molecular and clinicopathological features	17
Issue Information ‐ Ed Board	17
Valproic acid increased the efficacy of EGFR TKIs on EGFR/TP53 co‐mutated lung cancers and downregulated mutant‐p53 levels	17
CircST6GALNAC6 Inhibits Glycolysis of Bladder Cancer by Regulating PRKN/HK1 Signaling Pathway	17
NMI promotes tumor progression and gemcitabine resistance in pancreatic cancer via STAT3‐IFIT3 axis	17
FOXM1‐Cx31 Axis Drives Pancreatic Cancer Stem Cell‐Like Properties and Chemoresistance	15
	14
Potentially functional genetic variants in interferon regulatory factor family genes are associated with colorectal cancer survival	14
Insulin‐like growth factor (IGF) and hepatocyte growth factor (HGF) in follicular fluid cooperatively promote the oncogenesis of high‐grade serous carcinoma from fallopian tube epithelial cells: Disse	14
RETRACTED: LINC02381 aggravates breast cancer through the miR‐1271‐5p/FN1 axis to activate PI3K/AKT pathway	14
A rohitukine derivative IIIM‐290 induces p53 dependent mitochondrial apoptosis in acute lymphoblastic leukemia cells	13
Inhibition of the RBMS1/PRNP axis improves ferroptosis resistance‐mediated oxaliplatin chemoresistance in colorectal cancer	13
	13
Phosphoproteomics of extracellular vesicles integrated with multiomics analysis reveals novel kinase networks for lung cancer	12
Systematical identification of key genes and regulatory genetic variants associated with prognosis of esophageal squamous cell carcinoma	12
The Mechanism of TRIM21 Inhibiting the Invasion and Migration of ccRCC by Stabilizing ASS1	12
PLEK2 mediates metastasis and invasion via α5‐nAChR activation in nicotine‐induced lung adenocarcinoma	12
Tectoridin inhibits the growth of bladder cancer by regulating PI3K/MAPK pathway through RAB27B	12
γ‐Tocotrienol enhances autophagy of gastric cancer cells by the regulation of GSK3β/β‐Catenin pathway	12
Characterizing Genetic Susceptibility to Colorectal Cancer in Taiwan Through Genome‐Wide Association Study	12
Comprehensive analysis of PTEN‐related ceRNA network revealing the key pathways WDFY3‐AS2 ‐ miR‐21‐5p/miR‐221‐3p/miR‐222‐3p ‐ TIMP3 as potential biomarker in tumorigenesis and prognosis of kidney rena	12
Tex10 interacts with STAT3 to regulate hepatocellular carcinoma growth and metastasis	12
Wogonin Inhibits Ovarian Cancer by Activating the AMPK‐TET2‐5hmC Axis	12
Alkaliptosis induction counteracts paclitaxel‐resistant ovarian cancer cells via ATP6V0D1‐mediated ABCB1 inhibition	12
Withaferin A mediated changes of miRNA expression in breast cancer‐derived mammospheres	11
Dihydroartemisinin synergistically enhances the cytotoxic effects of oxaliplatin in colon cancer by targeting the PHB2‐RCHY1 mediated signaling pathway	11
Hyperactivation of MEK/ERK pathway by Ca2+/calmodulin‐dependent protein kinase kinase 2 promotes cellular proliferation by activating cyclin‐dependent kinases and minichromosome maintenance	11
HIF‐1α‐regulated stanniocalcin‐1 mediates gemcitabine resistance in pancreatic ductal adenocarcinoma via PI3K/AKT signaling pathway	11
Venetoclax overcomes resistance to all‐trans retinoic acid in a variant acute promyelocytic leukemia with TNRC18::RARA fusion	11
Sohlh2 Promotes the Progression of Hepatocellular Carcinoma via TGM2‐Mediated Autophagy	10
Nutlin‐3 acts as a DNA methyltransferase inhibitor to sensitize esophageal cancer to chemoradiation	10
Cover Image, Volume 62, Issue 4	10
GBP2 serves as a novel prognostic biomarker and potential immune microenvironment indicator in renal cell carcinoma	10
Integrating Multi‐Omics Data to Uncover Prostate Tissue DNA Methylation Biomarkers and Target Genes for Prostate Cancer Risk	10
Risk SNP‐mediated LINC01614 upregulation drives head and neck squamous cell carcinoma progression via PI3K/AKT signaling pathway	10
Cover Image, Volume 61, Issue 7	10
RAB6A functions as a critical modulator of the stem‐like subsets in cholangiocarcinoma	10
Blast phase of chronic myeloid leukemia with concurrent BCR::ABL1 and SET::NUP214: A report of two cases	10
Urinary parabens and breast cancer risk: Modification by LINE‐1 and LUMA global DNA methylation, and associations with breast cancer defined by tumor promoter methylation status	10
RELA promotes the progression of oral squamous cell carcinoma via TFAP2A‐Wnt/β‐catenin signaling	10
CDK4/6 and autophagy inhibitors synergize to suppress the growth of human head and neck squamous cell carcinomas	10
Forkhead Box Q1 is a novel regulator of autophagy in breast cancer cells	9
Effect of nonsteroidal anti‐inflammatory drugs (aspirin and naproxen) on inflammation‐associated proteomic profiles in mouse plasma and prostate during TMPRSS2‐ERG (fusion)‐driven prostate carc	9
The Effect of Gender on the Intestinal Flora of Colorectal Cancer Under Different Stages	9
Latrophilin‐3 as a downstream effector of the androgen receptor induces urothelial tumorigenesis	9
Regulation of SELENOF translation by eIF4a3: Possible role in prostate cancer progression	9
Overexpression of TYRO3 indicates poor prognosis and induces gastric cancer progression via AKT‐mTOR pathway	9

CircTCF25 serves as a sponge for miR‐206 to support proliferation, migration, and invasion of glioma via the Jak2/p‐Stat3/CypB axis	9
HET0016 attenuates the stemness of breast cancer cells through targeting CYP4Z1	9
CD137 Protein Expression Pattern Determines the Functional Role of Galectin‐9 in Colorectal Cancer	9
The dichotomy of regulatory B cells in cancer versus allergic disease	9
Predictive Value of Neutrophil Extracellular Traps in Neoadjuvant Chemotherapy for Muscle‐Invasive Bladder Cancer	9
EMX2 inhibits clear cell renal cell carcinoma progress via modulating Akt/FOXO3a pathway	9
microRNA‐2117 Negatively Regulates Liver Cancer Stem Cells Expansion and Chemoresistance Via Targeting SOX2	8
Targeting TAOK1 with resveratrol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo	8
	8
PTPN2 Expression in Hypopharyngeal Squamous Cell Carcinoma and Its Clinical Significance	8
Thyroglobulin as a negative marker for malignancy in canine and human breast tumors	8
ZNF480 Accelerates Chemotherapy Resistance in Breast Cancer by Competing With TRIM28 and Stabilizing LSD1 to Upregulate the AKT‐GSK3β‐Snail Pathway	8
Correction to “Plasma DNA Methylation‐Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1”	8
Methylation, Gene Expression, and Risk Genotypes at the TERT‐CLPTM1L Locus in Cervical Cancer	8
DSN1 Interaction With Centromere‐Associated Proteins Promotes Chromosomal Instability in Hepatocellular Carcinoma	8
IRF2BP2 drives lymphatic metastasis in OSCC cells by elevating mitochondrial fission‐dependent fatty acid oxidation	7
DUSP22 suppresses tumor progression by directly dephosphorylating AKT in non‐small cell lung cancer	7
The Parkinson's disease‐associated protein α‐synuclein inhibits hepatoma by exosome delivery	7
Histone lactylation facilitates hepatocellular carcinoma progression by upregulating endothelial cell‐specific molecule 1 expression	7
SIRT1 promotes doxorubicin‐induced breast cancer drug resistance and tumor angiogenesis via regulating GSH‐mediated redox homeostasis	7
Delta‐Like Homolog 2 Facilitates Malignancy of Hepatocellular Carcinoma via Activating EGFR/PKM2 Signaling Pathway	7
Nuclear receptor 4A1 (NR4A1) antagonists target paraspeckle component 1 (PSPC1) in cancer cells	7
Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma	7
SPI1‐mediated CXCL12 expression in bladder cancer affects the recruitment of tumor‐associated macrophages	7
Potentiated effects of lactate receptor GPR81 on immune microenvironment in breast cancer	7
PUS7 promotes the proliferation of colorectal cancer cells by directly stabilizing SIRT1 to activate the Wnt/β‐catenin pathway	7
C1QBP Promotes Prostate Cancer Progression and Lipid Accumulation by Negatively Regulating ALDH9A1	7
Cover Image, Volume 61, Issue 2	7
	7
MiR‐15a‐3p regulates ferroptosis via targeting glutathione peroxidase GPX4 in colorectal cancer	7
C5AR1‐induced TLR1/2 pathway activation drives proliferation and metastasis in anaplastic thyroid cancer	6
Issue Information ‐ Ed Board	6
	6
Issue Information ‐ Ed Board	6
Issue Information ‐ Ed Board	6
Issue Information ‐ Ed Board	6
Molecular and immune targets in cutaneous squamous cell carcinoma	6
	6
	6
Issue Information ‐ Ed Board	6
The transglutaminase 2 cancer cell survival factor maintains mTOR activity to drive an aggressive cancer phenotype	6
	6
VPS45 Contributes to the Progression of Hepatocellular Carcinoma by Triggering the Wnt/β‐Catenin Signaling Pathway	6
Issue Information ‐ Ed Board	6
	6
Role of RNA modifications in carcinogenesis and carcinogen damage response	6
Issue Information ‐ Ed Board	6
Corrigendum	6
Sciellin promotes the development and progression of thyroid cancer through the JAK2/STAT3 signaling pathway	6
Cover Image, Volume 63, Issue 5	6
AURKB targets DHX9 to promote hepatocellular carcinoma progression via PI3K/AKT/mTOR pathway	6
Energy Metabolic Profile in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma: A Preliminary Landscape of Warburg Effect in Oral Cancer	6
Knocking Down Ferredoxin 1 Inhibits the Progression of Colorectal Cancer and Regulates Cuproptosis via Mediating the Hippo Signaling Pathway	6
Targeting mitochondrial metabolism for metastatic cancer therapy	6
p110CUX1 promotes acute myeloid leukemia progression via regulating pyridoxal phosphatase expression and activating PI3K/AKT/mTOR signaling pathway	6
Issue Information ‐ Ed Board	6
Issue Information ‐ Ed Board	6
Issue Information ‐ Ed Board	6
Corrigendum	6
NUAK family kinase 2 is a novel therapeutic target for prostate cancer	6
Crucial role of glucosylceramide synthase in the regulation of stem cell‐like cancer cells in B16F10 murine melanoma	6
PKMYT1 induced by YAP/TEAD1 gives rise to the progression and worse prognosis of bladder cancer	6
An integrative analysis reveals the prognostic value and potential functions of PSMD11 in hepatocellular carcinoma	5
Issue Information ‐ Ed Board	5
	5
ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β‐catenin pathway	5
Transmembrane protein 147, as a potential Sorafenib target, could expedite cell cycle process and confer adverse prognosis in hepatocellular carcinoma	5
ITGB3‐enriched extracellular vesicles mediate the formation of osteoclastic pre‐metastatic niche to promote lung adenocarcinoma bone metastasis	5
Oncogenic fusion of CD63‐BCAR4 contributes cancer stem cell‐like properties via ALDH1 activity	5
Potentially functional genetic variants in RPS6KA4 and MAP2K5 in the MAPK signaling pathway predict HBV‐related hepatocellular carcinoma survival	5
Alternative splicing‐related long noncoding RNA ANRIL facilitates hepatocellular carcinoma by targeting the miR‐199a‐5p/SRSF1 axis and impacting Anillin	5
Saponin from Platycodi radix inactivates PI3K/AKT signaling pathway to hinder colorectal cancer cell proliferation, invasion, and migration through miR‐181c/d‐5p/RBM47	5
Issue Information ‐ Ed Board	5
	5
DNTT activation, TdT‐aided gene length mutation, and better prognosis in ATG‐based regimen allo‐HSCT in AML	5
Downregulation of C1R promotes hepatocellular carcinoma development by activating HIF‐1α‐regulated glycolysis	5
Circ_0007429/miR‐637/TRIM71/Ago2 axis participates in the regulation of proliferation, migration, invasion, apoptosis, and aerobic glycolysis of HCC	5
Drug‐target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk	5
The relationship of nutritional status with anticancer immunity and its prognostic value for head and neck cancer	5
Atypical BCR‐ABL1 transcript in mixed phenotype acute leukemia with bone marrow necrosis	5

Expression of Concern: Amplification of Cyclinl1 in Uterine Cervical Carcinoma Has Prognostic Implications	5
	5
Plasma cell‐free DNA methylome profiling in pre‐ and post‐surgery oral cavity squamous cell carcinoma	5
Tumor‐derived extracellular vesicles confer 5‐fluorouracil resistance in esophageal cancer via long noncoding RNA AC116025.2 delivery	5
Oscillatory hypoxia induced gene expression predicts low survival in human breast cancer patients	5
14‐3‐3σ/Stratifin and p21 limit AKT‐related malignant progression in skin carcinogenesis following MDM2‐associated p53 loss	5
Mass cytometry and transcriptomic profiling reveal PD1 blockade induced alterations in oral carcinogenesis	5
SYT7 as a Potential Prognostic Marker Promotes the Metastasis of Epithelial Ovarian Cancer Cells by Activating the STAT3 Pathway	5
miR‐506‐loaded gelatin nanospheres target PENK and inactivate the ERK/Fos signaling pathway to suppress triple‐negative breast cancer aggressiveness	4
Glutaminase potentiates the glycolysis in esophageal squamous cell carcinoma by interacting with PDK1	4
Blocking the ATR‐SerRS‐VEGFA pathway targets angiogenesis for UV‐induced cutaneous squamous cell carcinoma	4
Role of solute carrier transporters SLC25A17 and SLC27A6 in acquired resistance to enzalutamide in castration‐resistant prostate cancer	4
Loss of SETD2‐mediated downregulation of intracellular and exosomal miRNA‐10b determines MAPK pathway activation and multidrug resistance in renal cancer	4
Hepatitis B Virus X Protein Contributes to Hepatocellular Carcinoma via Upregulation of KIAA1429 Methyltransferase and mRNA m6A Hypermethylation of HSPG2/Perlecan	4
Protein tyrosine phosphatase nonreceptor type 2 exerts antimetastatic functions in pancreatic ductal adenocarcinoma	4
FOXD3 suppresses epithelial–mesenchymal transition through direct transcriptional promotion of SMAD7 in esophageal squamous cell carcinoma	4
Transcriptional activation of S100A2 expression by HIF‐1α via binding to the hypomethylated hypoxia response elements in HCC cells	4
A potential signaling axis between RON kinase receptor and hypoxia‐inducible factor‐1 alpha in pancreatic cancer	4
A novel hypoxia‐stimulated lncRNA HIF1A‐AS3 binds with YBX1 to promote ovarian cancer tumorigenesis by suppressing p21 and AJAP1 transcription	4
Common tumor‐suppressive signaling of thyroid hormone receptor beta in breast and thyroid cancer cells	4
Metabolic‐associated signature and hub genes associated with immune microenvironment and prognosis in bladder cancer	4
Eugenol modulates genomic methylation and inactivates breast cancer‐associated fibroblasts through E2F1‐dependent downregulation of DNMT1/DNMT3A	4
A novel high‐risk model identified by epithelial–mesenchymal transition predicts prognosis and radioresistance in rectal cancer	4
Silmitasertib in Combination With Cabozantinib Impairs Liver Cancer Cell Cycle Progression, Induces Apoptosis, and Delays Tumor Growth in a Preclinical Model	4
Long noncoding RNA TFAP2A‐AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR‐1297 and regulating TFAP2A expression	4
Autophagy modulates FSS‐induced epithelial–mesenchymal transition in hepatocellular carcinoma cells	4
Colorectal cancer risk susceptibility loci in a Swedish population	4
Baohuoside I inhibits resistance to cisplatin in ovarian cancer cells by suppressing autophagy via downregulating HIF‐1α/ATG5 axis	4
A two‐stage genome‐wide association study identified four potential early‐onset nonsmall cell lung cancer risk loci based on 26,652 participants in Chinese population	4
YTHDF1 enhances stemness and chemoresistance in triple‐negative breast cancer cells by upregulating SIAH2	4
Transglutaminase 2 enhances hepatocyte growth factor signaling to drive the mesothelioma cancer cell phenotype	4
CNOT4 suppresses nonsmall cell lung cancer progression by promoting the degradation of PAF1	4
Neoadjuvant endocrine therapy expands stromal populations that predict poor prognosis in estrogen receptor‐positive breast cancer	4
Molecular subtypes identified by multiomics analysis based on cuproptosis‑related genes precisely predict response to immunotherapy and chemotherapy in colorectal cancer	4
KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer	4
Combined inhibition of BET bromodomain and mTORC1/2 provides therapeutic advantage for rhabdomyosarcoma by switching cell death mechanism	4
SCR7, an inhibitor of NHEJ can sensitize tumor cells to ionization radiation	4
Translational relevance of SOS1 targeting for KRAS‐mutant colorectal cancer	4
Loss of CBX2 causes genomic instability and Wnt activation in high grade serous ovarian carcinoma cells	4
Identification of concurrent STAT3::RARA and RARA::STAT5b fusions in a variant APL case	4
Development of a scoring system for predicting primary resistance to venetoclax plus hypomethylating agents (HMAs) in acute myeloid leukemia patients	4
Issue Information ‐ Ed Board	4
SN‐38, an active metabolite of irinotecan, inhibits transcription of nuclear factor erythroid 2‐related factor 2 and enhances drug sensitivity of colorectal cancer cells	4
PRMT1 inhibition promotes ferroptosis sensitivity via ACSL1 upregulation in acute myeloid leukemia	4
Curcuminoid PBPD induces cuproptosis and endoplasmic reticulum stress in cervical cancer via the Notch1/RBP‐J/NRF2/FDX1 pathway	4
Novel MLL/KMT2A‐MON2 fusion in a child with therapy‐related acute myeloid leukemia after treatment for acute promyelocytic leukemia	4
Identification of ATAD3A as a key regulator in non‐small cell lung cancer by promoting STAT3‐induced cell proliferation and tumor angiogenesis	4
Sulforaphane covalently interacts with the transglutaminase 2 cancer maintenance protein to alter its structure and suppress its activity	4
Conditional deletion of mTOR discloses its essential role in early B‐cell development	4
Cip2a induces arginine biosynthesis and promotes tumor progression in non‐small cell lung cancer	4
Homologous recombination repair gene mutations in colorectal cancer favors treatment of immune checkpoint inhibitors	4